Delivery Order SPE2DB20D3103-SPE2DB24FP9H7

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.94 firm fixed-price delivery order is for the supply of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a medication used for the treatment of respiratory conditions. The award is not associated with a specific set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,503.69, is for the supply of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a medication used in respiratory treatments. The contract has a firm fixed price pricing type and runs through March 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, with an ID of SPE2DB20D2014|SPE2DB25FA24R, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,038.26, is for the supply of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a respiratory medication. The award has an ultimate completion date of November 4, 2024 and was issued on November 1, 2024. This contract is a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a medical product. The contract has a Ceiling Value of $1,218.25 and an Ultimate Completion Date of April 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,785.70 firm fixed-price delivery order is for the supply of Arformoterol 15 mcg/2 ml solution, a pharmaceutical product used in the treatment of respiratory conditions. The contract has an ultimate completion date of September 18, 2024 and was awarded on September 17, 2024. This award does not utilize a set-aside designation. Amerisourcebergen,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,478.52, is a Delivery Order contract for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of July 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,140.02 firm-fixed-price delivery order contract is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.24 Firm Fixed Price Delivery Order is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,076.73, is a firm fixed-price delivery order for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a prescription medication. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,045.60, is a Delivery Order for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of November 4, 2024, and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP9H7
    Delivery Order

This federal contract award, valued at $2,106.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565483180 - ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML. The contract is a delivery order with a firm fixed price, and the ultimate completion date is August 19, 2024.

Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. The primary contracting agency is the DLA, which supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 10:30 AM